What CSP Technologies does

CSP Technologies, now operating as Aptar Active Material Science, is a wholly-owned operating subsidiary of AptarGroup, Inc. (NYSE: ATR), headquartered in Auburn, Alabama. Founded in 1996 and integrated into AptarGroup following a 2015 Wendel Group acquisition and subsequent 2024 Aptar consolidation, the company specializes in active material science packaging for the pharmaceutical, medical device, diagnostics, probiotics, and food industries.

Its commercial offering is built on the proprietary 3-Phase Activ-Polymer platform technology, which enables the development of custom-engineered active packaging solutions (films, blisters, vials, seals, and closures) that adsorb moisture, scavenge oxygen/VOCs/odors, or — in newer extensions — emit controlled gases for sterilization. The product family includes Activ-Film, Activ-Blister, Activ-Vial, Activ-Seal, Pharmapuck, and Avanti Active Cap, alongside newer specialty platforms such as N-Sorb (nitrosamine mitigation, accepted into the FDA Emerging Technology Program), Dual-Guard (simultaneous moisture and oxygen control), and ActivShield (chlorine dioxide-based medical device sterilization). The technology is protected by 500+ patents worldwide and has secured multiple FDA approvals and ISO 13485:2016 certification for U.S. and France operations.

Revenue is generated through three streams: (1) direct sales of proprietary active packaging components to pharma, medical device, and diagnostics manufacturers; (2) licensing and co-development of the Activ-Polymer platform with regional partners; and (3) Xcelerate development services spanning feasibility assessment, extractables testing, stability studies, and regulatory submission support. Pricing is custom and quote-based, structured under multi-year enterprise contracts. The company operates four production sites across the U.S. (Auburn, AL; New Jersey), France (Niederbronn-les-Bains), and China (Guangzhou), with sales coverage in Japan and an Asia-Pacific commercial footprint anchored by a 2023 Porton partnership. Customers include Quidel Corporation, UAS Labs, and an unnamed rechargeable implantable neurostimulator manufacturer.

Name

CSP Technologies

Legal name

APTARGROUP, INC.

Website

https://csptechnologies.com

Company type

Public

Founded year

2015

Operating status

Operating

Headcount range

251–500 employees

Short description

CSP Technologies (Aptar Active Material Science) is an active material science subsidiary of AptarGroup (NYSE: ATR) that develops FDA-validated, proprietary Activ-Polymer-based packaging — including films, blisters, vials, and closures — to protect pharmaceutical, medical device, diagnostics, and probiotic products from moisture, oxygen, and contaminants.

Ownership category

akta.pro rank

Product category

Active Pharmaceutical Packaging Materials

NAICS

Plastics Packaging Film and Sheet (including Laminated) Manufacturing (326112), Plastics Product Manufacturing (3261), Medical Equipment and Supplies Manufacturing (33911), Packaging and Labeling Services (56191)

SIC

Miscellaneous Plastics Products (3080), Plastics Products, Nec (3089)

akta.pro primary industry

Pharmaceutical & Medical Plastic Packaging Manufacturing (IMANAEAK)

akta.pro secondary industry

Sustainable Cosmetic Packaging (Refillable, PCR, Mono-material, Reusable) (IMALAJAM)

Keywords

• Active packaging solutions
• Pharmaceutical packaging materials
• Moisture control packaging
• Desiccant packaging technology
• Headspace management solutions

Headquarters

HQ city

Auburn

HQ country

United States

HQ region

North America

Offices7 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Technology or R&D, Personnel, Marketing or Sales, Infrastructure

Revenue model

1. Active Packaging Solutions: Sale of proprietary active packaging products including Activ-Film, Activ-Blister, Activ-Vial, Activ-Seal, and Pharmapuck. Products are sold directly to pharmaceutical manufacturers, medical device companies, and diagnostics firms. Revenue derived from unit sales and custom engineering contracts.
2. Technology Licensing and Co-development: Licensing of proprietary Activ-Polymer™ technology platform and co-development partnerships for custom packaging solutions. Strategic collaborations with regional manufacturers for technology deployment.
3. Development Services (Xcelerate): Comprehensive development services from feasibility assessment through commercialization including compatibility studies, solution design, extractables testing, stability studies, regulatory submission support, and post-commercialization support.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels6 records

Core offering

CSP Technologies (now Aptar Active Material Science) designs and manufactures proprietary active packaging products built on its 3-Phase Activ-Polymer™ platform to adsorb moisture, scavenge oxygen and VOCs, mitigate nitrosamines, and sterilize medical devices. The company sells films, blisters, vials, closures, scavenging devices, and integrated filling systems to pharmaceutical manufacturers, medical device companies, diagnostic firms, and food producers. It also offers custom development services from feasibility through regulatory submission and commercialization.

Product overview

Aptar Active Material Science (formerly CSP Technologies) is an active material science company offering a comprehensive portfolio of innovative packaging solutions built on its proprietary 3-Phase Activ-Polymer™ platform technology. The product portfolio centers on the Activ™ family of products including Activ-Blister™ for oral solid dose blister packaging, Activ-Film™ for strip and cassette integration, Activ-Vial™ for desiccated vials and bottles, and Activ-Seal™ for closures with integrated desiccant. Specialized variants include N-Sorb™ for nitrosamine mitigation, Dual-Guard for dual moisture/oxygen control, and ActivShield™ for sterilization. Additional offerings include Pharmapuck™ scavenging devices, TruDraw® aseptic sampling, Avanti Active Cap for probiotics, and SEAWELL™ for seafood. The company provides comprehensive Xcelerate Development Services supporting customers from feasibility through commercialization.

Differentiator

Problem solved

Functional benefit

Brands

• 3-Phase Activ-Polymer™: Proprietary platform technology enabling development of innovative, highly engineered material science based solutions for product stability across therapeutic areas
• Activ-Film™
• Activ-Blister™
• Activ-Vial™
• ActivShield™
• N-Sorb
• Activ-Seal™
• Pharmapuck™
• TruDraw®
• Xcelerate

Products and services

• 3-Phase Activ-Polymer™ Platform Technology Foundational proprietary material science platform enabling custom-engineered active packaging solutions that adsorb moisture, scavenge oxygen/VOCs/odors, emit aromas, or reduce pathogens. Used across pharmaceutical, medical device, diagnostics, and food applications.
• Activ-Blister™ Active blister packaging that controls internal atmosphere of individual cavities to protect oral solid dose pharmaceuticals from moisture and oxygen. Adhesive-free and integrates without changes to existing packaging line footprint. FDA-approved for HIV prevention medicine.
• Activ-Film™ Active film material integrated into packaging components to control relative humidity and oxygen, eliminate odors, and reduce VOCs. Used in diagnostic test kits, implantable medical devices, and pharmaceutical products. FDA-approved for rechargeable implantable neurostimulator.
• Activ-Vial™ One-piece flip-top desiccated vials and bottles with co-molded active particles creating a microclimate that protects probiotics, diagnostic test strips, and pharmaceutical products from moisture and environmental conditions.
• Activ-Seal™ Closures Closure with gas scavenging technology built directly into an induction-sealed, tamper-evident screw cap; orifice-reducing element with moisture, VOC, and odor management positioned on the underside for permanent product protection.
• N-Sorb™ Nitrosamine mitigation solution that captures nitrosamine precursors from headspace to inhibit nitrosamine formation without drug reformulation. Reduces nitrosamine formation by up to 28% and is part of FDA's Emerging Technology Program.
• Dual-Guard Active Material Science Technology Dual-active technology that simultaneously controls moisture and oxygen for pharmaceutical drugs and medical devices, ideal for sensitive formulations requiring comprehensive protection against multiple degradation pathways. Won 2025 Pharma Innovation Award.
• ActivShield™ Sterilization Technology Portable sterilization technology for medical devices and instruments using chlorine dioxide gas emitted from Activ-Film material. Requires no power source, addresses EtO safety concerns, and targets rural, military, and healthcare facility applications.
• Pharmapuck™ Scavenging device integrated into nearly any container for oral solid dose products that controls moisture, oxygen absorption, and counteracts volatile organic compound odors. Molded-in desiccant eliminates sachet breakage or spillage risk.
• TruDraw® Aseptic Sampling System Aseptic milk sampling system co-developed with QualiTru for liquid dairy products; combines QualiTru TruStream sanitary sampling ports with Aptar sampling vial technology and provides tamper-evident security seal.
• Avanti Active Cap Cap technology for probiotics and nutraceuticals that integrates active material science for moisture protection and product stability.
• SEAWELL™ Seafood Packaging System Seafood packaging system featuring next-generation patent-pending technology for extending seafood shelf life through moisture control.
• Xcelerate Development Services Comprehensive service offering from feasibility assessment to commercial launch that expedites the packaging process for moisture, oxygen, and volatile compound-sensitive medicines; includes stability studies, validation, and regulatory submission support.
• Activ-Vial™ Automatic Filling Line Complete ready-to-deploy production system for probiotic commercialization including Activ-Vial filling, labeling, and shrink sleeve application.
• cGMP Early-Stage Clinical Manufacturing Site cGMP-compliant early-stage clinical manufacturing site in New Jersey offering clinical packaging services for tablet and capsule-based drug products.

Quantifiable outcome

• N-Sorb reduces nitrosamine formation by up to 28%
• +4 more outcomes

Named customers3 records

Segments7 records

Ideal customer profiles5 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature10 records

Partnerships

Five partnerships are on record, tiered core and minor.

• ProAmpaccoreStrategic or Co-development Partner · 9 February 2024Strategic collaboration to launch new active material science packaging solution. High-performance, moisture-adsorbing flexible packaging powered by Activ-Polymer™ technology delivers fully-integrated protection for moisture-sensitive products.
• PortoncoreStrategic or Co-development Partner · 8 August 2023Strategic collaboration to bring Activ-Blister™ technology to Asia-Pacific market. Expands regional manufacturing and market presence in Asia-Pacific region.
• FreeThink TechnologiescoreTechnology or Integration · 6 March 2019Partnership integrating FreeThink's ASAPprime® accelerated shelf-life determination technology with Activ-Blister™ solutions. Enables 'right the first time' approach to stability challenges.
• QualiTruminorStrategic or Co-development Partner · 10 October 2018Co-developed TruDraw® aseptic milk sampling system. QualiTru's TruStream® sanitary sampling ports combined with Aptar's sampling vial technology for dairy industry applications.
• PCI Pharma ServicescoreStrategic or Co-development Partner · 18 September 2018Strategic collaboration for breakthrough Activ-Blister™ solutions. PCI provides contract packaging services incorporating Activ-Blister technology for enhanced shelf life and speed-to-market.

Scale indicators7 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• Multisorb Technologies: Direct competitor specializing in sorbent and active packaging solutions for pharmaceuticals and electronics. Both companies provide moisture-adsorbing and oxygen-scavenging components integrated into drug and diagnostic packaging, serving overlapping pharma and diagnostics customers.
• Sanner Group: German-based manufacturer of desiccant closures and active packaging for pharmaceuticals and diagnostics. Comparable to CSP's Activ-Seal and Activ-Vial products for moisture-control in tablets, capsules, and diagnostic test strips.
• Clariant Healthcare Packaging: Provides desiccants, oxygen scavengers, and pharmaceutical packaging intermediates including the EQius brand. Targets the same pharma and nutraceutical desiccant headspace management use cases as CSP's Activ-Polymer platform.
• Datwyler Holding (Pharma Packaging): Swiss manufacturer of elastomer closures and pharma packaging components, including coated stoppers and prefilled syringe systems. Operates in overlapping pharma primary packaging space with comparable regulatory and customer-focus profile.

Broad incumbents

• West Pharmaceutical Services: Large-cap primary packaging and drug delivery components supplier for injectables and biologics. Operates broader in pharmaceutical containment and delivery while addressing overlapping moisture and barrier challenges for sensitive drug products.
• Gerresheimer AG: Global pharmaceutical packaging manufacturer producing glass and plastic primary packaging. Serves the same pharma customers as CSP, with broader portfolio including vials, syringes, and prefillable systems rather than specialty active packaging.
• Schott AG (Pharmaceutical Packaging): Pharmaceutical glass and specialty materials manufacturer with primary packaging for injectables and diagnostics. Comparable pharmaceutical customer base and regulatory positioning, but glass-focused rather than active polymer.
• AptarGroup Pharma (parent division): The parent conglomerate's broader pharma franchise spans dispensing closures, elastomers, and drug delivery devices. Provides commercial reach and cross-sell synergies that channel demand toward CSP's active material science unit while partially overlapping on customer relationships.
• AMCOR Healthcare: Global flexible and rigid packaging incumbent with healthcare packaging including blister films and barrier laminates. Comparable in scale and pharma customer base; partners with CSP via ProAmpac for active material science integration into flexible packaging.
• Sonoco Products (ThermoSafe): Diversified packaging conglomerate with healthcare and protective packaging segments. Overlaps with CSP's diagnostic test kit and temperature-sensitive pharma packaging use cases at a broader portfolio level.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/@aptarcsptechnologies8577
• LinkedInlinkedin.com/company/csp-technologies-inc.

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Subsidiaries1 record

Funding overview

Funding rounds1 record

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about CSP Technologies